Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Veradigm Inc. (MDRX:NASDAQ), powered by AI.
Veradigm Inc. is currently trading at $4.85. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Veradigm Inc. on Alpha Lenz.
View Veradigm Inc.'s valuation metrics on Alpha Lenz.
“Veradigm Inc.'s ROE is -7.3%. Explore profitability and growth together.”
Ask for details →Veradigm Inc. is a healthcare technology company specializing in data-driven solutions that connect providers, payers, and life science organizations. The company’s core offerings include electronic health records (EHR), practice management software, and analytics tools designed to optimize clinical, financial, and operational outcomes. It serves over 180,000 physicians and supports 2,700 hospitals through platforms that enhance care coordination, patient engagement, and population health management. Veradigm leverages its extensive healthcare data network to deliver actionable insights for clinical research, revenue cycle management, and value-based care initiatives. Historically known as Allscripts, the company rebranded in 2023 to reflect its focus on scalable, AI-enhanced solutions. Despite recent regulatory challenges, including a 2024 Nasdaq suspension for delayed financial filings, Veradigm remains a significant player in healthcare IT, bridging gaps across the ecosystem through interoperable technology and data interoperability standards.
“Veradigm Inc.'s ROE is -7.3%. Explore profitability and growth together.”
Ask for details →Veradigm Inc. (ticker: MDRX) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 2,450 employees.
The current price is $4.85 with a P/E ratio of -x and P/B of -x.
ROE is -7.27% and operating margin is -3.33%. Annual revenue is $588M.